Because colligin 2 is detected in a spectrum from morphologically normal to severely disfigured glioma blood vessels, it potentially may become in use as a marker for active angiogenesis or serve as a link to targeted anti‐angiogenic strategies. This evidence concerns the gene SERPINH1 and glioma.